KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to $30.7 million.

  • Fulgent Genetics' Shares Outstanding (Diluted Average) rose 109.48% to $30.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.7 million, marking a year-over-year increase of 109.48%. This contributed to the annual value of $31.0 million for FY2022, which is 3.87% down from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Shares Outstanding (Diluted Average) is $30.7 million, which was up 109.48% from $30.7 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Shares Outstanding (Diluted Average) ranged from a high of $31.2 million in Q1 2022 and a low of $29.5 million during Q1 2023
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $30.8 million (2021), whereas its average is $30.6 million.
  • In the last 5 years, Fulgent Genetics' Shares Outstanding (Diluted Average) soared by 4267.83% in 2021 and then tumbled by 545.45% in 2023.
  • Over the past 5 years, Fulgent Genetics' Shares Outstanding (Diluted Average) (Quarter) stood at $31.0 million in 2021, then fell by 0.04% to $31.0 million in 2022, then dropped by 3.07% to $30.0 million in 2023, then increased by 1.34% to $30.4 million in 2024, then rose by 1.09% to $30.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $30.7 million for Q3 2025, versus $30.7 million for Q2 2025 and $30.8 million for Q1 2025.